Edwards Lifesciences announced today that its Sapien M3 mitral valve replacement system received FDA approval for mitral ...
The US Food and Drug Administration has approved the Sapien M3 system for transseptal transcatheter mitral valve replacement (TMVR) for use in patients with symptomatic moderate-to-severe mitral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results